Inspire Medical Systems insider plans sale of 1,200 shares

Inspire Medical Systems had an affiliate file a Form 144 notice to potentially sell 1,200 shares of its common stock through Morgan Stanley Smith Barney LLC on or about 12/02/2025.

Rhea-AI Filing Summary

Inspire Medical Systems had an affiliate file a Form 144 notice to potentially sell 1,200 shares of its common stock through Morgan Stanley Smith Barney LLC on or about 12/02/2025. The shares have an aggregate market value of $151,608.00 based on the information provided. Common shares outstanding were 29,056,434 at the time referenced. The seller acquired these 1,200 shares on 03/17/2023 by exercising stock options and paying in cash on that date.

Over the past three months, the same account conducted 10b5-1 sales of 2,000 common shares on 11/28/2025, generating gross proceeds of $254,960.00. The notice includes a representation that the seller does not know of undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Inspire Medical Systems (INSP) shares are covered by this Form 144?

The notice covers a proposed sale of 1,200 shares of Inspire Medical Systems common stock, to be sold through Morgan Stanley Smith Barney LLC.

What is the approximate market value of the INSP shares in this planned Form 144 sale?

The 1,200 common shares listed in the notice have an aggregate market value of $151,608.00 based on the figures provided.

When were the INSP shares in this Form 144 acquired and how were they paid for?

The 1,200 shares were acquired on 03/17/2023 through previously exercised stock options, with the purchase price paid in cash on the same date.

What prior INSP share sales are disclosed for the past three months?

The filing lists 10b5-1 sales for Shawn T McCormick of 2,000 common shares on 11/28/2025, generating $254,960.00 in gross proceeds.

How many Inspire Medical Systems common shares were outstanding at the time referenced?

The table reports 29,056,434 common shares of Inspire Medical Systems outstanding at the time referenced in the notice.

What representation does the seller make in this Inspire Medical Systems Form 144 notice?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/02/2025 - 04:27 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001454092
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	INSPIRE MEDICAL SYSTEMS INC.
SEC File Number	001-38468
Address of Issuer	5500 Wayzata Blvd., Suite 1600 Golden Valley MINNESOTA 55416
Phone	844-672-4357
Name of Person for Whose Account the Securities are To Be Sold	SHAWN T MCCORMICK
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1200	151608.00	29056434	12/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/17/2023	Previously Exercised Stock Options	Issuer			1200	03/17/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SHAWN T MCCORMICK 5500 Wayzata Blvd., Suite 1600 Golden Valley MN 55416	COMMON	11/28/2025	2000	254960.00

144: Remarks and Signature

Remarks
Date of Notice	12/02/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Shawn T McCormick
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)